SavedAdd your journal

Journals / Endokrinolojide Diyalog Dergisi / 2010 / Cilt: 7 - Sayı: 1

Pharmacotherapy in insulin resistance

İnsülin direncinde farmakoterapi

Mustafa ŞAHİN
Tuncay DELİBAŞI
Pages
42–46
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review will focus on pharmacotherapy in insulin resistance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Insulin resistance is believed to be the origin of metabolic syndrome and type 2 diabetes mellitus.
📊
Key Findings & Data:The primary treatments for insulin resistance are exercise and weight loss.
💡
Conclusion & Impact:This review will focus on pharmacotherapy in insulin resistance.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Insulin resistance is believed to be the origin of metabolic syndrome and type 2 diabetes mellitus. The primary treatments for insulin resistance are exercise and weight loss. This review will focus on pharmacotherapy in insulin resistance.

Özet

İnsülin direnci, metabolik sendrom ve tip 2 diyabetin kökeni olarak düşünülmektedir. Insülin direncinde esas tedavi diyet ve egzersizdir. Bu derleme insülin direncinde farmakoterapi üzerine odaklanacaktır.

🔖

Cite This Article

ŞAHİN, M., DELİBAŞI, T. (2022). Pharmacotherapy in insulin resistance. Endokrinolojide Diyalog Dergisi, Cilt: 7 - Sayı: 1, 42–46. https://ajindex.com/articles/500777

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Satman I, Yilmaz T, Sengül A, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6
  2. Lipscombe LL, Hux JETrends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population- based study. Lancet 2007;369:750-6
  3. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insülin-dependent diabetes mellitus J Clin Invest 1994;94:1714-21
  4. Zangeneh F, Kudva YC, Basu A. Insülin sensitizers. Mayo Clin Proc 2003;78:471-9
  5. Consensus Development Conference on Insülin Resistance. 5-6 November 1997. American Diabetes Association.Diabetes Care 1998;21:310-4
  6. Ingelsson E, Arnlöv J, Sundström J, Risérus U, Michaëlsson K, Byberg L. Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance. Eur J Cardiovasc Prev Rehabil 2009;16:28-33
  7. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C: Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 1997;60:651-6
  8. Reaven GM. Pathophysiology of insülin resistance in human disease. Physiol Rev. 1995;75:473-86
  9. Godsland IF, Stevenson JC. Insülin resistance: syndrome or tendency? Lancet 1995;346:100-3
  10. Fonseca VA. Rationale for the use of insülin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus. Am J Med 2007;120:18-25
  11. Bonora E, Formentini G, Calcaterra F, et al. HOMA-estimated insülin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-41
  12. Dagdelen, Selcuk; Yildirim, Tolga; Erbas, Tomris Metabolik sendrom tanı kriterleri hakkında yaşanan küresel kargaşa: Kılavuzların anlaşamadıðı nokta nedir? - Derleme 2008 Cilt:8 Sayı:2 Nisan 13. Shah K, Stufflebam A, Hilton TN, Sinacore DR, Klein S, Villareal DT. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. obesity (silver spring) 2009;23. [Epub ahead of print] 14. Rector RS, Warner SO, Liu Y, et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Ph